ISSUE
posterior segment • innovation • enlightenment
3 09 | 12 | 21
PIE M A G A ZINE ’ S D A ILY CONGR E S S NE W S ON T HE P O S T E RIOR S E GME N T
HIGHLIGHTS New in Myopia 04 What’s Management? Check out some of the latest treatment methods
EURETINA 2021 Presents…
pachychoroid 05 The spectrum — Take a
closer look at the latest therapeutic options
The first-ever Kreissig Award for Excellence in Retinal Research
Software — A 10 AIgame-changer in
ophthalmic practice
by Nick Eustice
Published by
Matt Young CEO & Publisher
Hannah Nguyen COO & CFO
Robert Anderson Media Director
Gloria D. Gamat Chief Editor
Mapet L. Poso Editor
Brandon Winkeler International Business Development Graphic Designers
Maricel Salvador Kelsey Roode Writers
Elisa DeMartino Hazlin Hassan Nick Eustice Olawale Salami Tan Sher Lynn Media MICE Pte. Ltd.
6001 Beach Road, #19-06 Golden Mile Tower, Singapore 199589 Tel. Nos.: +65 8186 7677 | +1 302 261 5379 Email: enquiry@mediamice.com www.mediaMICE.com
piemagazine.org
A
high point of this year’s EURETINA conference was the inaugural presentation of the Kreissig Award for Excellence in Retinal Research and the accompanying keynote lecture by its recipient — Dr. Ogugua Okonkwo. Established just last year, the Kreissig Award for Excellence in Retinal Research is given by the Association for Research in Vision and Ophthalmology (ARVO) Foundation, in recognition of “the next generation of curious, enterprising investigators who seek to optimize functional outcomes for patients needing retinal surgery”. Dr. Okonkwo was introduced by EURETINA President Dr. Frank G. Holz, who highlighted his 19 years of experience at the Eye Foundation Hospital in Lagos, Nigeria. During this time, Dr. Holz described him as instrumental in developing one of the most outstanding surgical centers in all of Africa, devoting a great deal of time and effort to training generations of retinal surgeons.
Exploring various avenues of neuroprotection strategy for NACRAO Dr. Okonkwo began his lecture, entitled “Exploring Neuroprotective Strategy for NonArteritic Central Retinal Artery Occlusion”, by explaining the condition his research aims to treat. Central retinal artery occlusion, or CRAO, is an ocular variant or analogue of acute ischemic stroke (AIS). These strokes of the retina cause a very sudden loss of vision, which can become permanent without prompt and effective treatment to prevent the death of neurons. This presentation focused on the non-arteritic (NA) variety of CRAO, whose cause is known to be thromboembolism at the narrowest site of the central retinal artery (CRA), the point of dural penetration. It is the rapid and often complete blockage of blood flow caused by this embolism that makes the condition’s onset so sudden, and which makes the danger to the blocked-off neurons so severe. >> continued on Page 3